Presynaptic modulation by somatostatin in the rat neostriatum is altered in a model of parkinsonism

Journal of Neurophysiology

Volumn 108, Issue 4, 2012, Pages 1032-1043

  López Huerta, Violeta G ^a   Blanco Hernández, Eduardo ^a   Bargas, José ^a   Galarraga, Elvira ^a  

^a INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

Author keywords

6 hydroxydopamine; Feedback inhibition; Presynaptic modulation; Spiny projection neurons

Indexed keywords

OXIDOPAMINE; SOMATOSTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; GLOBUS PALLIDUS; HOMEOSTASIS; MALE; NEOSTRIATUM; NONHUMAN; PARKINSONISM; PRESYNAPTIC INHIBITION; PRESYNAPTIC NERVE; PRIORITY JOURNAL; RAT; VOLTAGE CLAMP;

ANIMALS; DISEASE MODELS, ANIMAL; INHIBITORY POSTSYNAPTIC POTENTIALS; MALE; NEOSTRIATUM; ORGAN CULTURE TECHNIQUES; PARKINSONIAN DISORDERS; PRESYNAPTIC TERMINALS; RATS; RATS, WISTAR; SOMATOSTATIN;

EID: 84865078205     PISSN: 00223077     EISSN: 15221598     Source Type: Journal    
DOI: 10.1152/jn.00244.2012     Document Type: Article

References (67)

1. Aceves JJ, Rueda-Orozco PE, Hernández R, Plata V, Ibañez-Sandoval O, Galarraga E, Bargas J. Dopaminergic presynaptic modulation of nigral afferents: its role in the generation of recurrent bursting in substantia nigra pars reticulata neurons. Front Sys Neurosci 5: 6, 2011.
2. Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci 12: 366-375, 1989.
3. Antonopoulos J, Dori I, Dinopoulos A, Chiotelli M, Parnavelas JG. Postnatal development of the dopaminergic system of the striatum in the rat. Neurosci 110: 245-256, 2002.
4. Asanuma M, Ogawa N, Sora YH, Pongdhana K, Haba K, Mori A. Alterations of somatostatin and its modulation by levodopa in MPTP-treated mouse brain. J Neurol Sci 100: 155-160, 1990.
5. Augood SJ, Kiyama H, Faull RL, Emson PC. Dopaminergic D1 and D2 receptor antagonists decrease prosomatostatin mRNA expression in rat striatum. Neurosci 44: 35-44, 1991.
6. Barnes TD, Kubota Y, Hu D, Jin DZ, Graybiel AM. Activity of striatal neurons reflects dynamic encoding and recoding of procedural memories. Nature 437: 1158-1161, 2005.
7. Boehm S, Betz H. Somatostatin inhibits excitatory transmission at rat hippocampal synapses via presynaptic receptors. J Neurosci 17: 4066-4075, 1997.
8. Bolam JP. Microcircuits of the striatum. In: Handbook of Brain Microcircuits, edited by Shepherd GM, Grillner S. Oxford: Oxford Univ. Press, 2010.
9. Breese GR, Knapp DJ, Criswell HE, Moy SS, Papadeas ST, Blake BL. The neonate-6-hydroxydopamine-lesioned rat: a model for clinical neuroscience and neurobiological principles. Brain Res Rev 48: 57-73, 2005.
10. Carman LS, Gage FH, Shults CW. Partial lesion of the substantia nigra: relation between extent of lesion and rotational behavior. Brain Res 553: 275-283, 1991.
11. Chan CS, Glajch KE, Gertler TS, Guzman JN, Mercer JN, Lewis AS, Goldberg AB, Tkatch T, Shigemoto R, Fleming SM, Chetkovich DM, Osten P, Kita H, Surmeier DJ. HCN channelopathy in external globus pallidus neurons in models of Parkinson's disease. Nat Neurosci 14: 85-92, 2011.
12. Clements JD, Silver RA. Unveiling synaptic plasticity: a new graphical and analytical approach. Trends Neurosci 23: 105-113, 2000.
13. Coulson DT, Brockbank S, Quinn JG, Murphy S, Ravid R, Irvine GB, Johnston JA. Identification of valid reference genes for the normalization of RT qPCR gene expression data in human brain tissue. BMC Mol Biol 9: 46, 2008.
14. Czubayko U, Plenz D. Fast synaptic transmission between striatal spiny projection neurons. Proc Natl Acad Sci USA 99: 15764-15769, 2002.
15. Day M, Wang Z, Ding J, An X, Ingham CA, Shering AF, Wokosin D, Ilijic E, Sun Z, Sampson AR, Mugnaini E, Deutch AY, Sesack SR, Arbuthnott GW, Surmeier DJ. Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat Neurosci 9: 251-259, 2006.
16. Dehorter N, Guigoni C, Lopez C, Hirsch J, Eusebio A, Ben-Ari Y, Hammond C. Dopamine-deprived striatal GABAergic interneurons burst and generate repetitive gigantic IPSCs in medium spiny neurons. J Neurosci 29: 7776-7787, 2009.
17. Dehorter N, Michel FJ, Marissal T, Rotrou Y, Matrot B, Lopez C, Humphries MD, Hammond C. Onset of pup locomotion coincides with loss of NR2C/D-mediated cortico-striatal EPSCs and dampening of striatal network immature activity. Front Cell Neurosci 5: 24, 2011.
18. DeLong MR, Wichmann T. Circuits and circuit disorders of the basal ganglia. Arch Neurol 64: 20-24, 2007.
19. Espino A, Llorens J, Calopa M, Bartrons R, Rodriguez-Farré E, Ambrosio S. Cerebrospinal dopamine metabolites in rats after intrastriatal administration of 6-hydroxydopamine or 1-methyl-4-phenylpyridinium ion. Brain Res 669: 19-25, 1995.
20. Flores-Barrera E, Laville A, Plata V, Tapia D, Bargas J, Galarraga E. Inhibitory contribution to suprathreshold corticostriatal responses: an experimental and modeling study. Cell Mol Neurobiol 29: 719-731, 2009.
21. Flores-Barrera E, Vizcarra-Chacón BJ, Tapia D, Bargas J, Galarraga E. Different corticostriatal integration in spiny projection neurons from direct and indirect pathways. Front Syst Neurosci 4: 15, 2010.
22. Flores-Barrera E, Vizcarra-Chacón BJ, Bargas J, Tapia D, Galarraga E. Dopaminergic modulation of corticostriatal responses in medium spiny projection neurons from direct, and indirect pathways. Front Syst Neurosci 5: 15, 2011.
23. Galarraga E, Bargas J, Martínez-Fong D, Aceves J. Spontaneous synaptic potentials in dopamine-denervated neostriatal neurons. Neurosci Lett 81: 351-355, 1987.
24. Galarraga E, Vilchis C, Tkatch T, Salgado H, Tecuapetla F, Pérez-Rosello T, Pérez-Garci E, Hernández-Echeagaray E, Surmeier DJ, Bargas J. Somatostatinergic modulation of firing pattern and calcium activated potassium currents in medium spiny neostriatal neurons. Neuroscience 146: 537-554, 2007.
25. Gillies G. Somatostatin: the neuroendocrine story. Trends Pharmacol Sci 18: 87-95, 1997.
26. Guzmán JN, Hernández A, Galarraga E, Tapia D, Laville A, Vergara R, Aceves J, Bargas J. Dopaminergic modulation of axon collaterals interconnecting spiny neurons of the rat striatum. J Neurosci 23: 8931-8940, 2003.
27. 2receptors mediate striatal dopamine release. Brit J Pharmacol 128: 1346-1352, 1999.
28. Hoyer D, Bell GI, Berelowitz M, Epelbaum J, Feniuk W, Humphrey PP, O'Carroll AM, Patel YC, Schonbrunn A, Taylor JE, Reisine T. Classification and nomenclature of somatostatin receptors. Trends Pharmacol Sci 16: 86-88, 1995.
29. Hudson JL, van Horne CG, Stromberg I, Brock S, Clayton J, Masserano J, Hoffer BJ, Gerhardt GA. Correlation of apomorphine-and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats. Brain Res 626: 167-174, 1993.
30. Jáidar O, Carrillo-Reid L, Hernández A, Drucker-Colín R, Bargas J, Hernández-Cruz A. Dynamics of the Parkinsonian striatal microcircuit: entrainment into a dominant network state. J Neurosci 30: 11326-11336, 2010.
31. Javoy F, Agid Y, Bouvet D, Glowinski J. In vivo estimation of tyrosine hydroxylation in the dopaminergic terminals of the rat neostriatum. J Pharm Pharmacol 26: 179-185, 1974.
32. Kita H. GABAergic circuits of the striatum. Prog Brain Res 99: 51-72, 1993.
33. Koos T, Tepper JM, Wilson CJ. Comparison of IPSCs evoked by spiny and fast-spiking neurons in the neostriatum. J Neurosci 24: 7916-7922, 2004.
34. Lanneau C, Peineau S, Petit F, Epelbaum J, Gardette R. Somatostatin modulation of excitatory synaptic transmission between periventricular and arcuate hypothalamic nuclei in vitro. J Neurophysiol 84: 1464-1474, 2000.
35. Leresche N, Asprodini E, Emri Z, Cope DW, Crunelli V. Somatostatin inhibits GABAergic transmission in the sensory thalamus via presynaptic receptors. Neurosci 98: 513-522, 2000.
36. Liang L, DeLong MR, Papa SM. Inversion of dopamine responses in striatal medium spiny neurons and involuntary movements. J Neurosci 28: 7537-7547, 2008.
37. Lopez-Huerta VG, Tecuapetla F, Guzman JN, Bargas J, Galarraga E. Presynaptic modulation by somatostatin in the neostriatum. Neurochem Res 33: 1452-1458, 2008.
38. Lu JQ, Stoessl AJ. Somatostatin modulates the behavioral effects of dopamine receptor activation in parkinsonian rats. Neurosci 112: 261-266, 2002.
39. Magill PJ, Bolam JP, Bevan MD. Dopamine regulates the impact of the cerebral cortex on the subthalamic nucleus-globus pallidus network. Neurosci 106: 313-330, 2001.
40. Momiyama T, Zaborszky L. Somatostatin presynaptically Inhibits both GABA and glutamate release onto rat basal Forebrain cholinergic neurons. J Neurophysiol 96: 686-694, 2006.
41. Nilsson A, Fälth M, Zhang X, Kultima K, Sköld K, Svenningsson P, Andrén PE. Striatal alterations of secretogranin-1, somatostatin, prodynorphin, and cholecystokinin peptides in an experimental mouse model of Parkinson disease. Mol Cell Proteomics 8: 1094-1104, 2009.
42. Olias G, Viollet C, Kusserow H, Epelbaum J, Meyerhof W. Regulation and function of somatostatin receptors. J Neurochem 89: 1057-1091, 2004.
43. 2channels. J Neurophysiol 93: 2507-2519, 2005.
44. Piwko C, Thoss VS, Probst A, Hoyer D. Localization and pharmacological characterization of somatostatin recognition sites in the human cerebellum. Neuropharmacology 35: 713-23, 1996.
45. Ramirez JL, Mouchantaf R, Kumar U, Otero Corchon V, Rubinstein M, Low MJ, Patel YC. Brain somatostatin receptors are upregulated in somatostatin deficient mice. Mol Endocrinol 16: 1951-1963, 2002.
46. Reader TA, Dewar KM. Effects of denervation and hyperinnervation on dopamine and serotonin systems in the rat neostriatum: implications for human Parkinson's disease. Neurochem Int 34: 1-21, 1999.
47. 2channel current and its dopaminergic D2 modulation in developing neostriatal neurons. J Neurophysiol 94: 3771-3787, 2005.
48. Sanchez G, Rodriguez MJ, Pomata P, Rela L, Murer MG. Reduction of an afterhyperpolarization current increases excitability in striatal cholinergic interneurons in rat parkinsonism. J Neurosci 31: 6553-6564, 2011.
49. Schwarting RK, Huston JP. The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments. Prog Neurobiol 50: 275-331, 1996.
50. Schulz S, Händel M, Schreff M, Schmidt H, Höllt V. Localization of five somatostatin receptors in the rat central nervous system using subtypespecific antibodies. J Physiol Paris 94: 259-264, 2000.
51. Soghomonian JJ, Chesselet MF. Lesions of the dopaminergic nigrostriatal pathway alter preprosomatostatin messenger RNA levels in the striatum, the entopeduncular nucleus and the lateral hypothalamus of the rat. Neurosci 42: 49-59, 1991.
52. Sun QQ, Huguenard JR, Prince DA. Somatostatin inhibits thalamic network oscillations in vitro: actions on the GABAergic neurons of reticular nucleus. J Neurosci 22: 5374-5386, 2002.
53. Surmeier DJ, Carrillo-Reid L, Bargas J. Dopaminergic modulation of striatal neurons, circuits, and assemblies. Neurosci 198: 3-18, 2011.
54. Tallent MK, Siggins GR. Somatostatin depresses excitatory but not inhibitory neurotransmission in rat CA1 hippocampus. J Neurophysiol 78: 3008-3018, 1997.
55. Tatsuoka Y, Riskind PN, Beal MF, Martin JB. The effect of amphetamine on the in vivo release dopamine, somatostatin and neuropeptide Y from rat caudate nucleus. Brain Res 411: 200-203, 1987.
56. Taverna S, Ilijic E, Surmeier DJ. Recurrent collateral connections of striatal medium spiny neurons are disrupted in models of Parkinson's disease. J Neurosci 28: 5504-5512, 2008.
57. Tecuapetla F, Carrillo-Reid L, Guzmán JN, Galarraga E, Bargas J. Different inhibitory inputs onto neostriatal projection neurons as revealed by field stimulation. J Neurophysiol 93: 1119-1126, 2005.
58. Tecuapetla F, Carrillo-Reid L, Bargas J, Galarraga E. Dopaminergic modulation of short term synaptic plasticity at striatal inhibitory synapses. Proc Natl Acad Sci USA 104: 10258-10263, 2007.
59. Tecuapetla F, Koos T, Tepper JM, Kabbani N, Yeckel MF. Differential dopaminergic modulation of neostriatal synaptic connections of striatopallidal axon collaterals. J Neurosci 29: 8977-8990, 2009.
60. Tepper JM, Tecuapetla F, Koós T, Ibáñez-Sandoval O. Heterogeneity and diversity of striatal GABAergic interneurons. Front Neuroanat 4: 150, 2010.
61. Tseng KY, Kasanetz F, Kargieman L, Riquelme LA, Murer MG. Cortical slow oscillatory activity is reflected in the membrane potential and spike trains of striatal neurons in rats with chronic nigrostriatal lesions. J Neurosci 21: 6430-6439, 2001.
62. Tunstall MJ, Oorschot DE, Kean A, Wickens JR. Inhibitory interactions between spiny projection neurons in the rat striatum. J Neurophysiol 88: 1263-1269, 2002.
63. Ungerstedt U. 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. Eur J Pharmacol 5: 107-110, 1968.
64. Vasilaki A, Papasava D, Hoyer D, Thermos K. The somatostatin receptor (sst1) modulates the release of somatostatin in the nucleus accumbens of the rat. Neuropharmacol 47: 612-618, 2004.
65. Vergara R, Rick C, Hernández-López S, Laville JA, Guzmán JN, Galarraga E, Surmeier DJ, Bargas J. Membrane potential oscillations of striatal medium spiny neurons in a corticostriatal slice. J Physiol 553: 169-182, 2003.
66. 2currents in neostriatal neurons. Neurosci 109: 555-567, 2002.
67. Wilson CJ. Basal ganglia. In: The Synaptic Organization of the Brain. Oxford: Oxford Univ. Press, 2004, p. 361-414.